0.84
-0.009(-1.06%)
Currency In USD
| Previous Close | 0.85 |
| Open | 0.84 |
| Day High | 0.84 |
| Day Low | 0.84 |
| 52-Week High | 2.3 |
| 52-Week Low | 0.77 |
| Volume | 6,434 |
| Average Volume | 24,372 |
| Market Cap | 5.95M |
| PE | -0.09 |
| EPS | -9.64 |
| Moving Average 50 Days | 0.9 |
| Moving Average 200 Days | 1.24 |
| Change | -0.01 |
If you invested $1000 in DSS, Inc. (DSS) 10 years ago, it would be worth $0.95 as of March 14, 2025 at a share price of $0.842. Whereas If you bought $1000 worth of DSS, Inc. (DSS) shares 5 years ago, it would be worth $8.3 as of March 14, 2025 at a share price of $0.842.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
GlobeNewswire Inc.
Feb 26, 2025 1:30 PM GMT
ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air purification asset to Impact BioMedical Inc. (NYSE
DSS, Inc. Issues Letter to Shareholders
GlobeNewswire Inc.
Feb 03, 2025 1:50 PM GMT
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops assets to increase shareholder value, today issued th
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
GlobeNewswire Inc.
Sep 16, 2024 8:26 PM GMT
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of Impact BioMedical's initial public of